Cargando…

B-Cell-Based and Soluble Biomarkers in Body Liquids for Predicting Acute/Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation

Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is the main curative therapy for hematological malignancy such as leukemias, lymphomas, or multiple myelomas and some other hematological disorders. In this therapy, cure of hematological diseases relies on graft-versus-malignancy effect...

Descripción completa

Detalles Bibliográficos
Autores principales:	Juric, Mateja Kralj, Shevtsov, Maxim, Mozes, Petra, Ogonek, Justyna, Crossland, Rachel E., Dickinson, Anne M., Greinix, Hildegard T., Holler, Ernst, Weissinger, Eva M., Multhoff, Gabriele
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5238459/ https://www.ncbi.nlm.nih.gov/pubmed/28138325 http://dx.doi.org/10.3389/fimmu.2016.00660

Ejemplares similares

Immune Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation
por: Ogonek, Justyna, et al.
Publicado: (2016)

Milestones of Hematopoietic Stem Cell Transplantation – From First Human Studies to Current Developments
por: Juric, Mateja Kralj, et al.
Publicado: (2016)

Profiling Tissue and Biofluid miR-155-5p, miR-155(*), and miR-146a-5p Expression in Graft vs. Host Disease
por: Crossland, Rachel E., et al.
Publicado: (2021)

Expression of Serum microRNAs is Altered During Acute Graft-versus-Host Disease
por: Crossland, Rachel E., et al.
Publicado: (2017)

Serum and Extracellular Vesicle MicroRNAs miR-423, miR-199, and miR-93* As Biomarkers for Acute Graft-versus-Host Disease
por: Crossland, Rachel E., et al.
Publicado: (2017)

Editorial: Cellular Therapies: Past, Present and Future
por: Dressel, Ralf, et al.
Publicado: (2018)

Adiponectin and resistin in acute and chronic graft-vs-host disease patients undergoing allogeneic hematopoietic stem cell transplantation
por: Robak, Oliver, et al.
Publicado: (2016)

Cytomegalovirus-specific CD8+ T-cells are associated with a reduced incidence of early relapse after allogeneic stem cell transplantation
por: Varanasi, Pavankumar Reddy, et al.
Publicado: (2019)

Immunological and Translational Aspects of NK Cell-Based Antitumor Immunotherapies
por: Shevtsov, Maxim, et al.
Publicado: (2016)

Incidence and characteristics of invasive fungal diseases in allogeneic hematopoietic stem cell transplant recipients: a retrospective cohort study
por: Harrison, Nicole, et al.
Publicado: (2015)

Heat Shock Protein–Peptide and HSP-Based Immunotherapies for the Treatment of Cancer
por: Shevtsov, Maxim, et al.
Publicado: (2016)

Membrane Hsp70-supported cell-to-cell connections via tunneling nanotubes revealed by live-cell STED nanoscopy
por: Reindl, Judith, et al.
Publicado: (2019)

Successful Treatment of Early Relapsed High-Risk AML After Allogeneic Hematopoietic Stem Cell Transplantation With Biomodulatory Therapy
por: Kattner, Anna-Sophia, et al.
Publicado: (2020)

Tick-Borne Encephalitis Specific Lymphocyte Response after Allogeneic Hematopoietic Stem Cell Transplantation Predicts Humoral Immunity after Vaccination
por: Harrison, Nicole, et al.
Publicado: (2021)

Muscle Cramps and Neuropathies in Patients with Allogeneic Hematopoietic Stem Cell Transplantation and Graft-versus-Host Disease
por: Kraus, Peter D., et al.
Publicado: (2012)

Potential Novel Biomarkers in Chronic Graft-Versus-Host Disease
por: Crossland, Rachel E., et al.
Publicado: (2020)

Membrane heat shock protein 70: a theranostic target for cancer therapy
por: Shevtsov, Maxim, et al.
Publicado: (2018)

Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosis
por: Robin, Marie, et al.
Publicado: (2019)

Proteomic peptide profiling for preemptive diagnosis of acute graft-versus-host disease after allogeneic stem cell transplantation
por: Weissinger, E M, et al.
Publicado: (2013)

IL6-receptor antibody tocilizumab as salvage therapy in severe chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: a retrospective analysis
por: Kattner, Anna-Sophia, et al.
Publicado: (2020)

Psychometric properties of the Activities Scale for Kids-performance after allogeneic hematopoietic stem cell transplantation in adolescents and children: Results of a prospective study on behalf of the German-Austrian-Swiss GVHD Consortium
por: Lawitschka, Anita, et al.
Publicado: (2020)

Human CD8+ CD57- T(EMRA) cells: Too young to be called "old"
por: Verma, Kriti, et al.
Publicado: (2017)

A qualitative study on patients’ and their support persons’ preferences for receiving one longer consultation or two shorter consultations when being informed about allogeneic hematopoietic stem cell transplantation
por: Herrmann, Anne, et al.
Publicado: (2021)

Correction to: Psychometric properties of the Activities Scale for Kids-performance after allogeneic hematopoietic stem cell transplantation in adolescents and children: Results of a prospective study on behalf of the German-Austrian-Swiss GVHD consortium
por: Lawitschka, Anita, et al.
Publicado: (2021)

Novel Approaches to Improve the Efficacy of Immuno-Radiotherapy
por: Shevtsov, Maxim, et al.
Publicado: (2019)

Recent Developments in Cellular Immunotherapy for HSCT-Associated Complications
por: Reis, Monica, et al.
Publicado: (2016)

“This Graft-vs.-Host Disease Determines My Life. That's It.”—A Qualitative Analysis of the Experiences and Needs of Allogenic Hematopoietic Stem Cells Transplantation Survivors in Germany
por: Parisek, Mira, et al.
Publicado: (2021)

Impact of chronic graft-versus-host disease on quality of life and cognitive function of long-term transplant survivors after allogeneic hematopoietic stem cell transplantation with total body irradiation
por: Gruber, Isabella, et al.
Publicado: (2022)

Immune Reconstitution and Graft-Versus-Host Reactions in Rat Models of Allogeneic Hematopoietic Cell Transplantation
por: Zinöcker, Severin, et al.
Publicado: (2012)

Genetic Association of Hematopoietic Stem Cell Transplantation Outcome beyond Histocompatibility Genes
por: Gam, Rihab, et al.
Publicado: (2017)

Cytotoxic Pathways in Allogeneic Hematopoietic Cell Transplantation
por: Du, Wei, et al.
Publicado: (2018)

Allogeneic hematopoietic stem-cell transplantation for myelofibrosis
por: Zhang, Lining, et al.
Publicado: (2020)

Allogeneic Hematopoietic Cell Transplantation and Cellular Therapy
por: Kim, Hee-Je, et al.
Publicado: (2021)

Vaccination against pandemic H1N1 (2009) in patients after allogeneic hematopoietic stem cell transplantation: a retrospective analysis
por: Roll, D., et al.
Publicado: (2011)

Improved outcome of patients with graft-versus-host disease after allogeneic hematopoietic cell transplantation for hematologic malignancies over time: an EBMT mega-file study
por: Greinix, Hildegard T., et al.
Publicado: (2021)

Donor Vδ1(+) γδ T cells expand after allogeneic hematopoietic stem cell transplantation and show reactivity against CMV-infected cells but not against progressing B-CLL
por: Prinz, Immo, et al.
Publicado: (2013)

Use of the NIH consensus criteria in cellular and soluble biomarker research in chronic graft-versus-host disease: A systematic review
por: Milosevic, Emina, et al.
Publicado: (2022)

Magnetic nanoparticles in theranostics of malignant melanoma
por: Shevtsov, Maxim, et al.
Publicado: (2021)

Alemtuzumab-BEAM as conditioning for allogeneic hematopoietic stem cell transplantation in relapsed/refractory Hodgkin lymphoma: a single-center analysis
por: Rabitsch, W., et al.
Publicado: (2016)

Allogeneic Hematopoietic Stem Cell Transplantation in Cutaneous T-Cell Lymphomas
por: Dumont, Maëlle, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0jet2gnl8o766vq2cv5l7nvvjf